Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized-controlled clinical trial

References

• Alles MS, De Roos NM, Bakx JC, Van De Lisdonk E, Zock PL, Hautvast GA. 1999. Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr 69:64–69
   PubMed Web of Science ®Google Scholar
• Anderson AD, Mcnaught CE, Jain PK, Macfie J. 2004. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53:241–245
   PubMed Web of Science ®Google Scholar
• Association AD. 2004. Diagnosis and classification of diabetes mellitus. Diabetes Care 27:S5–S10
   PubMedGoogle Scholar
• Bonsu NK, Johnson CS, Mcleod KM. 2011. Can dietary fructans lower serum glucose? J Diabetes 3:58–66
   PubMed Web of Science ®Google Scholar
• Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. 2011. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol 48:257–273
   PubMed Web of Science ®Google Scholar
• Caesar R, Fak F, Backhed F. 2010. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 268:320–328
   PubMed Web of Science ®Google Scholar
• Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470–1481
   PubMed Web of Science ®Google Scholar
• Cani PD, Delzenne NM. 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 15:1546–1558
   PubMed Web of Science ®Google Scholar
• Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, et al. 2007. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50:2374–2383
   PubMed Web of Science ®Google Scholar
• Cani PD, Possemiers S, Van De Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, et al. 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving Glp-2-driven improvement of gut permeability. Gut 58:1091–1103
   PubMed Web of Science ®Google Scholar
• Cherbut C. 2003. Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc 62:95–99
   PubMed Web of Science ®Google Scholar
• Cornell RP. 1980. Mechanisms of acute hyperinsulinemia after kupffer cell phagocytosis. Am J Physiol 238:E276–E283
   PubMedGoogle Scholar
• Creely SJ, Mcternan PG, Kusminski CM, Fisher FM, Da Silva NF, Khanolkar M, Evans M, et al. 2007. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740–E747
   PubMed Web of Science ®Google Scholar
• Delzenne NM, Neyrinck AM, Cani PD. 2011a. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 10:S10 . doi: 10.1186/1475-2859-10-S1-S10
   PubMed Web of Science ®Google Scholar
• Delzenne NM, Neyrinck AM, Backhed F, Cani PD. 2011b. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7:639–646
   PubMed Web of Science ®Google Scholar
• Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PG, Neyrinck AM, Bindels LB, et al. 2013. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62:1112--1121
   PubMed Web of Science ®Google Scholar
• Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110:9066–9071
   PubMed Web of Science ®Google Scholar
• Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, et al. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60:2775–2786
   PubMed Web of Science ®Google Scholar
• Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, Mariat D, et al. 2010. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59:3049–3057
   PubMed Web of Science ®Google Scholar
• Fusunyan RD, Quinn JJ, Fujimoto M, Macdermott RP, Sanderson IR. 1999. Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation. Mol Med 5:631–640
   PubMed Web of Science ®Google Scholar
• Goldberg RB. 2009. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94:3171–3182
   PubMed Web of Science ®Google Scholar
• Jain PK, Mcnaught CE, Anderson AD, Macfie J, Mitchell CJ. 2004. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus. Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr 23:467–475
   PubMed Web of Science ®Google Scholar
• King GL, Loeken MR. 2004. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 122:333–338
   PubMed Web of Science ®Google Scholar
• Kolid S, Gibson GR. 2007. Prebiotic capacity of inulin-type fructans. J Nutr 137:2503s–2506s
   PubMed Web of Science ®Google Scholar
• Lecerf JM, Depeint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L, Cayzeele A, et al. 2012. Xylo-oligosaccharide (Xos) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while Xos alone only shows prebiotic properties. Br J Nutr 108:1847–1858
   PubMed Web of Science ®Google Scholar
• Malaguarnera M, Vacante M, Antic T, Giordano M, Chisari G, Acquaviva R, Mastrojeni S, et al. 2012. Bifidobacterium longum with fructo-oligosaccharides in patients with non-alcoholic steatohepatitis. Dig Dis Sci 57:545–553
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
   PubMed Web of Science ®Google Scholar
• Parnell JA, Reimer RA. 2009. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89:1751–1759
   PubMed Web of Science ®Google Scholar
• Place RF, Noonan EJ, Giardina C. 2005. HDAC inhibition prevents Nf-Kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I Kappa B alpha. Biochem Pharmacol 70:394–406
   PubMed Web of Science ®Google Scholar
• Pedersen C, Lefevre S, Peters V, Patterson M, Ghatei MA, Morgan LM, Frost GS. 2013. Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake. A dose-escalation study. Appetite 66:44–53
   PubMed Web of Science ®Google Scholar
• Pocock SJ. 1990. Clinical trials – a practical approach. New York (NY): John Wiley & Sons, Chichester
   Google Scholar
• Pourghassem Gargari B, Dehghan P, Aliasgharzadeh A, Asghari Jafar-Abadi M. 2013. Effects of high performance inulin supplementation on glycemic control and antioxidant status in women with type 2 diabetes. Diabetes Metab J 37:140–148
   PubMedGoogle Scholar
• Pyra KA, Saha DC, Reimer RA. 2012. Prebiotic fiber increases hepatic acetyl CoA carboxylase phosphorylation and suppresses glucose-dependent insulinotropic polypeptide secretion more effectively when used with metformin in obese rats. J Nutr 142:213–220
   PubMed Web of Science ®Google Scholar
• Serino M, Luche E, Gres S, Baylac A, Bergé M, Cenac C, Waget A, et al. 2012. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61:543–553
   PubMed Web of Science ®Google Scholar
• Sharman MJ, Volek JS. 2004. Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond) 107:365–369
   PubMed Web of Science ®Google Scholar
• Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. 2007. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enteral Nutr 31:119–126
   PubMed Web of Science ®Google Scholar
• Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105:16731–16736
   PubMed Web of Science ®Google Scholar
• Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y. 2007. Attenuation of obesity-induced adipose tissue inflammation in C3h/Hej mice carrying a toll-like receptor 4 mutation. Biochem Biophys Res Commun 354:45–49
   PubMed Web of Science ®Google Scholar
• Verhoef SP, Meyer D, Westerterp KR. 2011. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake. Br J Nutr 106:1757–1762
   PubMed Web of Science ®Google Scholar
• Weber TE, Kerr B J. 2006. Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells. Vet Immunol Immunopathol 113:139–147
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. 2005. Inflammation, stress, and diabetes. J Clin Invest 115:1111–1119
   PubMed Web of Science ®Google Scholar
• Yamashita K, Kawai KMI. 1984. Effects of fructooligosaccharides on blood glucose and serum lipids in diabetic subjects. Nutr Res 4:961–966
   Web of Science ®Google Scholar
• Yasuda K, Dawson HD, Wasmuth EV, Roneker CA, Chen C, Urban JF, Welch RM, et al. 2009. Supplemental dietary inulin influences expression of iron and inflammation related genes in young pigs. J Nutr 139:2018–2023
   PubMed Web of Science ®Google Scholar